Determination of Enterococcal Virulence Factors Expression and Impact of Biofilm Formation on Antimicrobial Susceptibility Pattern

Kinjal Prashant Patel; Summaiya Mulla

doi:10.21276/apalm.3182

Kinjal Prashant Patel Department of Microbiology, Apoorva Diagnostics & Health Care, Bhaktivedanta Hospital & Research Institute, Maharashtra, India
Summaiya Mulla Department of Microbiology, Govt. Medical College, Surat

DOI: https://doi.org/10.21276/apalm.3182

Keywords: Antimicrobial susceptibility, Biofilm, Enterococci, Gelatinase, Hemolysin, Virulence factors

Abstract

Introduction: Enterococcus spp. has become recognized as a significant cause of hospital-acquired infections. Two main virulence factors namely gelatinase and hemolysin of Enterococci have been proved to cause severe infections. In addition, biofilm formation is causing infection by enhancing the persistence of Enterococci in medical indwelling devices. Therefore, the study aimed to evaluate the presence of hemolysin, gelatinase, and biofilm formation in Enterococcus spp. and the impact of biofilm on antimicrobial susceptibility patterns. Materials & Methods: Total 104 Enterococcal isolates obtained from different clinical samples were included in the study for expression of virulence factors. All isolates were evaluated for biofilm formation by the tissue culture plate method. Hemolysin production was checked by using 5% sheep blood agar and gelatinase production by peptone yeast extract agar containing 3% gelatin. Antimicrobial susceptibility testing was done by the Vitek2 compact automated system. Results: Out of 104 isolates, 1(1%) were strong biofilm producers while 4(3.85% %) and 54(52%) were moderate and weak biofilm producers respectively. Hemolysin production was observed in 19(18%) isolates and gelatinase production was universal. Conclusion: Biofilm-producing strains showed higher resistance to beta-lactam drugs and high-level aminoglycosides. Hence, amongst three virulence factors, studying biofilm formation can be an important tool to develop a hospital’s antibiotic policy and other virulence factors can be helpful to understand the pathogenesis of infection caused by Enterococcus spp. as well as for antimicrobial usage strategies.

References

Richards M. J., Edwards J. R., Culver D. H. and Gaynes R. P. (2000) Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 21: 510–515.

Chow JW, Thal LA, Perri MB, Vazquez JA, Donabedian SM, Clewell DB. Plasmid associated hemolysin and aggregation substance production contributes to virulence in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1993; 37:2474-7.

Upadhyaya PG, Ravikumar KL, Umapathy BL. Review of virulence factors of Enterococcus: An emerging nosocomial pathogen. Indian J Med Microbiol 2009; 27:301-5.

Shankar V, Baghdayan AS, Huycke MM, Lindahl G, Gilmore MS. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun 1999; 67:193-200.

Jett BD, Huycke MM, Gilmore MS. Virulence of Enterococci. Clin Microbiol Rev 1994; 7: 462-78.

Jayanthi S, Ananthasubramanian N, Appalaraju B. Assessment of pheromone response in biofilm-forming clinical isolates of high-level gentamycin resistant Enterococcus faecalis. Indian J Med Microbiol 2008; 23:248-51.

Vergis EN, Shankar N, Chow JW, Hayden MK, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Muder RR. Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clin Infect Dis. 2002 Sep 1; 35(5):570-5.

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 18th Informational Supplement. CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.

Dupont H, Montravers P, Mohler J, Carbon C. Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis. Infect Immun 1998; 66:2570–5.

Stevens SX, Jensen HG, Jett BD, Gilmore MS. A hemolysin-encoding plasmid contributes to bacterial virulence in experimental Enterococcus faecalis endophthalmitis. Invest Ophthalmol Vis Sci 1992; 33:1650–6.

Schlievert PM, Gahr PJ, Assimacopoulos AP, et al. Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect Immun 1998; 66:218–23.

Fluit A. C, Schmitz F. J, Verhoef J. 2001; Frequency of isolation of pathogens from the bloodstream, nosocomial pneumonia, skin, and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis 20:188–191.

Fridkin S. K, Gaynes R. P. 1999; Antimicrobial resistance in intensive care units. Clin Chest Med 20:303–316.

Sandoe JAT, Witherden IR, Cove JH, Heritage J, Wilcox MH. Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J Med Microbiol. 2003 Jul; 52(Pt 7):547-550.

Garg S, Mohan B, Taneja N. Biofilm formation capability of enterococcal strains causing urinary tract infection vis-a-vis colonization and correlation with enterococcal surface protein gene. Indian J Med Microbiol. 2017 Jan-Mar; 35(1):48-52.

Tsikrikonis G, Maniatis AN, Labrou M, Ntokou E, Michail G, Daponte A, Stathopoulos C, Tsakris A, Pournaras S. Differences in biofilm formation and virulence factors between clinical and fecal enterococcal isolates of human and animal origin. Microb Pathog. 2012 Jun; 52(6):336-43.

Gilmore MS, Huycke MM, Daniel FS. Multidrug resistant Enterococci. The nature of the problem and an agenda for the future. Emerg Infect Dis 1998; 239-49.

Fallah F, Yousefi M, Pourmand MR, Hashemi A, Nazari Alam A, Afshar D. Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections. Microb Pathog. 2017 Jul; 108:85-90.